Genentech, founded in 1976, is a leading biotechnology company that specializes in the research, development, and manufacturing of pharmaceutical products. Its headquarters are located in South San Francisco, California, USA. As of 2023, Genentech has a workforce of over 15,000 employees.

The company is a pioneer in the biotechnology industry and has been instrumental in developing breakthrough treatments for various diseases, including cancer, multiple sclerosis, and rheumatoid arthritis. Genentech's innovative medicines have significantly improved patients' lives worldwide.

In terms of recent financial information, Genentech is a subsidiary of Roche Holding AG, a Swiss pharmaceutical company. As of 2022, Roche reported annual revenues of approximately 63 billion.